Ally Bridge Group as of March 31, 2022
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 21 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 11.7 | $16M | 285k | 55.31 | |
| Iveric Bio | 8.1 | $11M | 650k | 16.83 | |
| Guardant Health (GH) | 7.9 | $11M | 160k | 66.24 | |
| Arvinas Ord (ARVN) | 7.5 | $10M | 150k | 67.30 | |
| Cogent Biosciences (COGT) | 7.3 | $9.8M | 1.3M | 7.49 | |
| Miragen Therapeutics (VRDN) | 6.8 | $9.2M | 496k | 18.49 | |
| Fate Therapeutics (FATE) | 5.2 | $7.0M | 182k | 38.77 | |
| Nuvation Bio Com Cl A (NUVB) | 4.4 | $6.0M | 1.1M | 5.26 | |
| Cerevel Therapeutics Hldng I (CERE) | 4.4 | $6.0M | 170k | 35.01 | |
| Somalogic Class A Com | 4.4 | $5.9M | 735k | 8.02 | |
| Isoplexis Corp | 4.2 | $5.7M | 1.7M | 3.43 | |
| Rapid Micro Biosystems Class A Com (RPID) | 3.5 | $4.8M | 700k | 6.79 | |
| Nautilus Biotechnology (NAUT) | 3.5 | $4.7M | 1.1M | 4.34 | |
| Intellia Therapeutics (NTLA) | 3.2 | $4.4M | 60k | 72.67 | |
| Syros Pharmaceuticals | 3.0 | $4.0M | 3.4M | 1.19 | |
| Gossamer Bio (GOSS) | 2.9 | $3.9M | 450k | 8.68 | |
| Jounce Therapeutics | 2.8 | $3.7M | 550k | 6.79 | |
| Stoke Therapeutics (STOK) | 2.7 | $3.7M | 175k | 21.05 | |
| Sight Sciences (SGHT) | 2.7 | $3.6M | 315k | 11.56 | |
| Medavail Holdings Ord | 2.1 | $2.8M | 2.9M | 0.97 | |
| Verve Therapeutics (VERV) | 1.8 | $2.4M | 105k | 22.82 |
